Mikobeaute International (6574) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 霈方

Mikobeaute International (6574) reported revenue of NT$87.7 million for Oct 2026, +57.7% year on year and +23.4% from the previous month. Revenue for Jan–Oct 2026 was NT$713.3 million (+45.1% year on year).

Revenue for Oct 2026 was a record high (previous high: Jun 2026, NT$76.7 million). →

Year-on-year revenue growth: 11 months in a row. →

In Oct 2026, it ranked No. 82 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$53.3 million24/10Nov 2024 NT$63.5 millionDec 2024 NT$54.8 millionJan 2025 NT$43.7 millionFeb 2025 NT$44 million25/02Mar 2025 NT$63.3 millionApr 2025 NT$57.3 millionMay 2025 NT$49.9 millionJun 2025 NT$44.1 million25/06Jul 2025 NT$55.3 millionAug 2025 NT$39.1 millionSep 2025 NT$39.2 millionOct 2025 NT$55.6 million25/10Nov 2025 NT$61 millionDec 2025 NT$69.2 millionJan 2026 NT$66.4 millionFeb 2026 NT$61.4 million26/02Mar 2026 NT$67.6 millionApr 2026 NT$72.9 millionMay 2026 NT$69.6 millionJun 2026 NT$76.7 million26/06Jul 2026 NT$68.4 millionAug 2026 NT$71.4 millionSep 2026 NT$71.1 millionOct 2026 NT$87.7 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$87.7 million+57.7%+23.4%
Sep 2026NT$71.1 million+81.3%-0.5%
Aug 2026NT$71.4 million+82.8%+4.4%
Jul 2026NT$68.4 million+23.7%-10.8%
Jun 2026NT$76.7 million+73.9%+10.2%
May 2026NT$69.6 million+39.4%-4.5%
Apr 2026NT$72.9 million+27.1%+7.8%
Mar 2026NT$67.6 million+6.8%+10.0%
Feb 2026NT$61.4 million+39.8%-7.5%
Jan 2026NT$66.4 million+52.2%-4.0%
Dec 2025NT$69.2 million+26.2%+13.5%
Nov 2025NT$61 million-4.0%+9.7%
Oct 2025NT$55.6 million+4.4%+41.8%
Sep 2025NT$39.2 million-20.7%+0.3%
Aug 2025NT$39.1 million-16.8%-29.4%
Jul 2025NT$55.3 million+36.4%+25.5%
Jun 2025NT$44.1 million+9.4%-11.7%
May 2025NT$49.9 million-2.3%-12.9%
Apr 2025NT$57.3 million-3.1%-9.4%
Mar 2025NT$63.3 million+39.9%+44.0%
Feb 2025NT$44 million+16.6%+0.7%
Jan 2025NT$43.7 million+5.1%-20.4%
Dec 2024NT$54.8 million-12.3%-13.7%
Nov 2024NT$63.5 million+15.7%+19.2%
Oct 2024NT$53.3 million-12.3%+7.8%

Jan–Oct 2026 cumulative: NT$713.3 million (+45.1% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Mikobeaute International vs PEC / Mikobeaute International vs Lotus Pharm / Mikobeaute International vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

本月較去年同期增加57.74%,主係美學健康通路業務持續成長,帶動相關服務及醫材銷售增加。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16